Cytomegalovirus Reactivation in a Patient With Extensively Pretreated Multiple Myeloma During Daratumumab Treatment

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)e9-e11
JournalClinical Lymphoma, Myeloma and Leukemia
Volume19
Issue number1
DOIs
Publication statusPublished - 1 Jan 2019

Cite this

@article{6604c0587c3442558086b149b4a1e1e6,
title = "Cytomegalovirus Reactivation in a Patient With Extensively Pretreated Multiple Myeloma During Daratumumab Treatment",
keywords = "CD38 antibodies, CMV, Infectious complication, Plasma cell dyscrasia, Viral infection",
author = "Frerichs, {Kristine A.} and Bosman, {Patricia W.C.} and Nijhof, {Inger S.} and Sonja Zweegman and {van de Donk}, {Niels W.C.J.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.clml.2018.10.002",
language = "English",
volume = "19",
pages = "e9--e11",
journal = "Clinical Lymphoma Myeloma and Leukemia",
issn = "2152-2650",
publisher = "Cancer Media Group",
number = "1",

}

TY - JOUR

T1 - Cytomegalovirus Reactivation in a Patient With Extensively Pretreated Multiple Myeloma During Daratumumab Treatment

AU - Frerichs, Kristine A.

AU - Bosman, Patricia W.C.

AU - Nijhof, Inger S.

AU - Zweegman, Sonja

AU - van de Donk, Niels W.C.J.

PY - 2019/1/1

Y1 - 2019/1/1

KW - CD38 antibodies

KW - CMV

KW - Infectious complication

KW - Plasma cell dyscrasia

KW - Viral infection

UR - http://www.scopus.com/inward/record.url?scp=85055743960&partnerID=8YFLogxK

U2 - 10.1016/j.clml.2018.10.002

DO - 10.1016/j.clml.2018.10.002

M3 - Article

VL - 19

SP - e9-e11

JO - Clinical Lymphoma Myeloma and Leukemia

JF - Clinical Lymphoma Myeloma and Leukemia

SN - 2152-2650

IS - 1

ER -